Overview
Lobbying Costs
1,500,000€ - 1,749,999€
Financial year: Jan 2022 - Dec 2022
Lobbyists (Full time equivalent)
2.8 Fte (16)
Lobbyists with EP accreditation
5
High-level Commission meetings
45
Lobbying Costs over the years
-
Info
MedTech Europe (MTE)
EU Transparency Register
433743725252-26 First registered on 26 Dec 2016
Goals / Remit
MedTech Europe is the European trade association representing the medical technology manufacturers that produce diagnostics, medical devices and digital health solutions in Europe. MedTech Europe's mission is to make safe and innovative medical technology available to more people.
MedTech Europe aims to:
* promote the value and contribution of the medical technology industry
* raise awareness about the role that innovative medical technologies play in providing solutions to Europe’s ever-growing healthcare needs
* anticipate and respond to new business trends
* develop scientific expertise on questions of economic, medical and technical nature related to the medical technology industry
* collect, develop and communicate reliable data on a wide variety of issues to its members
* provide services, support and information that add value to our members
* encourage the contribution of the medical technology industry to EU industrial competitiveness and sustainable healthcare systemsMain EU files targeted
* Internal market legislation and any other legislation which impacts upon medical technologies
* Files under the responsibility of the DG SANTE, DG GROW, DG RTD, DG ENV, DG CNECT, DG JUST, DG TRADE, DG TAXUD and DG NEAR with particular focus on health, medical devices and IVDs, digital health and Innovation
* Regulation (EU) 2017/746 on in vitro diagnostic medical devices and Regulation (EU) 2017/745 on medical devices
* Blood, tissues and cells legislation
* Animal by-products legislation
* The General Data Protection Regulation (EU) 2016/679
* Late payments directive
* Policies, Initiatives related to Antimicrobial Resistance (AMR) and Healthcare-Associated Infections (HAIs) and Non Communicable diseases (NCD)
* Regulation 2021/2282 on Health Technology Assessment* Cross-Border Health Care
* Health system performance assessments / EU semester
* Environmental regulations and their implementation (e.g., REACH Regulation, CLP Regulation, RoHS Directive,POPs and Biocidal Products Regulation, Fluorinated Greenhouse Gases Regulation)
* The European Green Deal, in particular the Chemicals Strategy for Sustainability and initiatives under the Circular Economy Action Plan to revise the Batteries Legislation, the Packaging and Packaging Waste Llegislation, the Waste Framework and WEEE Directives and set up a Framework Regulation for more Ssustainable Products (Ecodesign Regulation) and a Regulation for Product and Business Environmental Footprint
* Artificial intelligence Act
* Data Act
*Cyber Resilience Act
* Directive on measures for a high common level of cybersecurity across the Union *(NIS Directive 2)
* Representative Action Directive ("Collective Redress")
* Product Liability Directive
* AI Liability Directive
* Withdrawal of the United Kingdom from the European Union
* Bilateral and multilateral trade agreements
* Customs procedures and tariffs
* Resolution of technical barriers to trade
*COUNCIL REGULATION establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014
*Pharmaceutical strategy for Europe
*European Health Union
* Regulation for a European Health Data Space
*Corporate Sustainability Due Diligence Directive
*Critical Raw Materials ActAddress
Head Office
40 rue Joseph II
Brussels 1000 - 3
BELGIUMEU Office
40 rue Joseph II
Brussels 1000 - 3
BELGIUMWebsite
-
People
Total lobbyists declared
16
Employment time Lobbyists 25% 8 10% 8 Lobbyists (Full time equivalent)
2.8
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
5 accreditations were / are live (in bold) for the selected state of 21 Nov 2024
Name Start date End Date Sigrid Linher 07 Oct 2024 07 Oct 2025 Estefania Guzman Cordero 07 Oct 2024 07 Oct 2025 Judith KALINA 04 Jul 2024 03 Jul 2025 Cristina Mura 18 Jun 2024 17 Jun 2025 Irina Floriana Kubinschi 20 Aug 2024 20 Aug 2025 Gianluca VIOLANTE 23 Mar 2024 04 Oct 2024 Judith KALINA 23 Jun 2023 27 Jun 2024 Mr Giovanni DALLE NOGARE 24 Oct 2023 20 Mar 2024 Mr Alexander Olbrechts 16 Mar 2023 16 Mar 2024 Ms Jessica IMBERT 23 Feb 2023 11 Mar 2024 Mr Benjamin KRASA 29 Nov 2022 23 Feb 2023 Mr Giovanni DALLE NOGARE 14 Oct 2022 14 Oct 2023 Judith KALINA 27 Apr 2022 27 Apr 2023 Mr Serge Bernasconi 18 Feb 2020 01 Mar 2021 Ms Tanja Valentin 17 Dec 2019 17 Dec 2020 Mr Michael STRÜBIN 26 Nov 2019 26 Nov 2020 Ms Emma KOLLATOU 25 Sep 2019 25 Sep 2020 Mr Giovanni DALLE NOGARE 07 Sep 2019 05 Sep 2020 Mr YVES VERBOVEN 30 Mar 2019 01 Apr 2020 Ms Jessica IMBERT 30 Mar 2019 01 Apr 2020 Mr Serge Bernasconi 01 Feb 2019 01 Feb 2020 Valentina Laurenzia Ancona 01 Feb 2019 31 Jul 2019 Timea Rezi-Kato 01 Feb 2019 05 Sep 2019 Ms Tanja Valentin 10 Jan 2019 17 Dec 2019 Mr Michael STRÜBIN 28 Nov 2018 26 Nov 2019 Mr YVES VERBOVEN 06 Apr 2018 30 Mar 2019 Ms Jessica IMBERT 06 Apr 2018 30 Mar 2019 Mr Serge Bernasconi 24 Jan 2018 23 Jan 2019 Valentina Laurenzia Ancona 24 Jan 2018 23 Jan 2019 Timea Rezi-Kato 24 Jan 2018 23 Jan 2019 Ms Tanja Valentin 24 Jan 2018 10 Jan 2019 Mr Merlin RIETSCHEL 09 Dec 2017 31 Mar 2018 Mr Oliver Bisazza 21 Nov 2017 31 Mar 2018 Mr JESUS RUEDA RODRIGUEZ 23 Jan 2017 14 Jan 2018 NEHA DAVE 23 Jan 2017 10 Jun 2017 Mr Serge Bernasconi 23 Jan 2017 14 Jan 2018 Valentina Laurenzia Ancona 23 Jan 2017 14 Jan 2018 Ms Petra Zollner 23 Jan 2017 14 Jan 2018 John BRENNAN 23 Jan 2017 14 Jan 2018 Ms Marinela Claudia Gherman 23 Jan 2017 14 Jan 2018 Ms Thecla Sterk 23 Jan 2017 21 Jul 2017 Mr YVES VERBOVEN 23 Jan 2017 14 Jan 2018 Timea Rezi-Kato 23 Jan 2017 13 Jan 2018 Ms Tanja Valentin 23 Jan 2017 14 Jan 2018 Complementary Information
A total of 16 persons are involved in activities covered by the Register.
I have adapted the percentages per individuals (not the total number of persons) so we now have 8 people (instead of 2 in our previous submission) working 10% of their time on those type of activities
We have included the following persons:
1 CEO @ 10%
4 FTE (1@25% and 3@10%) from our regulatory team (mainly involved on MDR and IVDR)
5 FTE (3@25% and 2@10%) from our external affairs team
2 FTE (2@10%) from our Legal team
1 FTE (@25%) from our digital team
2 FTE (2@25%) from our sustainability team
1 FTE (@25%) from our international departmentPerson in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Trade and business associations
-
Networking
Affiliation
*AMR One Health Network:EC led multistakeholder platform to deal with the cross-border health threat of AMR
*AMR Patient Group: the AMR Patient Group is an initiative of Health First Europe and is comprised of national patient associations from across Europe. The group aims to address the gap in awareness at the patient-level about the danger of antibiotic misuse and the lack of effective infection prevention measures
*AP4HE:an intersectoral initiative that brings together a diverse group of NGOs, think-tanks, associations, companies, and individuals
*Data saves lives:A multi-stakeholder initiative with the aim of raising wider patient and public awareness about the importance of health data
*EFLM: it connects National Societies of Clinical Chemistry and Laboratory Medicine and creates a platform for all European “Specialists in Laboratory Medicine
*ESAE: The leading European organisation bringing together Association professionals
*European Internet Forum: MEP-led network of digital policy stakeholders and a neutral, transparent and non-partisan platform to better understand the Internet and its foreseeable impact on Europe's economy, society and governance
*European Policy Center:an independent, not-for-profit think tank dedicated to fostering European integration through analysis and debate
*Friends of Europe: A think tank that supports a multilateral world in which all levels of governance, the private and civil society sectors, as well as citizens, cooperate to solve common challenges
*GMTA: The Global Medical Technology Alliance (GMTA) member associations represent companies that produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our represented companies produce nearly 85 percent of the health care technology purchased and utilized annually around the world.
*HTA Stakeholder Network: Stakeholder organisations with an interest in Union cooperation on HTA, including patient associations, consumer organisations, health technology developer associations, health professional organisations and other relevant non-governmental organisations in the field of health, including clinical and learned societies.Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2022 - Dec 2022
Lobbying costs for closed financial year
1,500,000€ - 1,749,999€
Major contributions in closed year
Type Name Amount Grant H2020 - EURIPHI project 30,186€ Intermediaries for closed year
Name Amount incisive health 100,000€ - 199,999€ edelman 50,000€ - 99,999€ pirovano management 25,000€ - 49,999€ harwood levitt consulting (hlc) 25,000€ - 49,999€ ogilvy 25,000€ - 49,999€ Intermediaries for current year
Name pirovano management harwood levitt edelman evoke incisive Closed year Costs
1,500,000€ - 1,749,999€
Other financial info
Our cost is estimated @1.6 million. It accounts for:
* the staff cost (a prorata 12.5% or 25%) of the 16 FTE involved.
* the admin cost linked to those 16 FTE
* the operational expenses
* the outsourced activities (consultants) e.g. Ogilvy, Incisive, HLC,...
-
EU Structures
Groups (European Commission)
eHealth Stakeholder Group#E02769#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=2769 #Member #C#Industry#Commission expert group "Industrial Forum"#E03743#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3743 #Member #C#Industry, SMEs#Antimicrobial Resistance One Health Network#E03853#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3853 #Member #C#Industry#Medical Device Coordination Group#X03565#https://ec.europa.eu/transparency/expert-groups-register/screen/expert-groups/consult?lang=en&groupID=3565 #Observer #C#Industry#03 - Clinical Investigation and Evaluation (CIE)#04 - Post-Market Surveillance and Vigilance (PMSV)#02 - Standards#08 - EUDAMED#13 - Annex XVI #09 - Unique Device Identification (UDI)#06 - Borderline and Classification (B&C)#10 - International Matters#11 - In vitro Diagnostic Medical Devices (IVD)#12 - Nomenclature#07 - New Technologies
Groups (European Parliament)
Climate change, biodiversity and sustainable development#Cancer
Communication activities
None
Other activities
None declared
Meetings
Meetings
45 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 10 Sep 2024 Location Brussels Subject Preventing the circumvention of EU sanctions on sensitive goods Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Attending - Valdis Dombrovskis (Executive Vice-President)
Other Lobbyists -
Date 10 Sep 2024 Location Brussels Subject High-level executive roundtable: preventing the circumvention of EU sanctions on sensitive goods. Cabinet Cabinet of Commissioner Mairead Mcguinness Attending - Patricia Reilly (Cabinet member)
- Mairead McGuinness (Commissioner)
Other Lobbyists -
Date 19 Apr 2024 Location Brussels Subject Exchange of views on Innovative Health Initiative (IHI JU) DG Research and Innovation Attending - Marc Lemaître (Director-General)
-
Date 11 Apr 2024 Location Brussels Subject Meeting with representatives from the Medtech Europe Cardiovascular sector group. Cabinet Cabinet of Commissioner Stella Kyriakides Attending - Ralf Kuhne (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 05 Dec 2023 Location Brussels Subject Exchange of views with MedTech on the regulatory framework for medical devices Cabinet Cabinet of Commissioner Stella Kyriakides Attending - Karolina Herbout-Borczak (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 21 Nov 2023 Location video-call Subject Healthcare system in the European Green Deal; specific input on the Packaging and Packaging Waste Regulation proposal Cabinet Cabinet of Vice-President Maroš Šefčovič Portfolio Energy Union Attending - Helena Braun (Cabinet member)
-
Date 21 Nov 2023 Location Virtual Subject Healthcare system in the European Green Deal; specific input on the Packaging and Packaging Waste Regulation proposal Cabinet Cabinet of Commissioner Virginijus Sinkevičius Portfolio Environment, Oceans and Fisheries Attending - Elena Montani (Cabinet member)
-
Date 13 Jul 2023 Location Brussels, Belgium Subject Medical devices legislation and EU sanctions Cabinet Cabinet of Commissioner Mairead Mcguinness Portfolio Financial services, financial stability and Capital Markets Union Attending - Katherine Power (Cabinet member)
Other Lobbyists -
Date 03 May 2023 Location On line Subject Meeting with the newly appointed CEO of MedTech Europe to discuss the medical device legislative framework Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Daphne von Buxhoeveden (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 24 Mar 2023 Location Brussels Subject China, Russia sanctions and IP Waiver. DG Trade Attending - Sabine Weyand (Director-General)
-
Date 16 Feb 2023 Location Brussels Subject Introduction to the new CEO. DG Health Emergency Preparedness and Response Authority Attending - Pierre Delsaux (Director-General)
-
Date 09 Nov 2022 Location Virtual Subject Implementation of EU Chemicals Strategy and the REACH revision Cabinet Cabinet of Commissioner Virginijus Sinkevičius Portfolio Environment, Oceans and Fisheries Attending - Elena Montani (Cabinet member)
-
Date 09 Nov 2022 Location video-call Subject Implementation of EU Chemicals Strategy and the REACH revision Cabinet Cabinet of Executive Vice-President Frans Timmermans Portfolio European Green Deal Attending - Helena Braun (Cabinet member)
-
Date 31 Aug 2022 Location video Subject shortage of semi conductors Cabinet Cabinet of Executive Vice-President Valdis Dombrovskis Portfolio An Economy that Works for People Attending - Zaneta Vegnere (Cabinet member)
-
Date 08 Jul 2022 Location videoconference Subject product liability directive Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 05 Feb 2021 Location Teams meeting Subject Meeting with MedTech Europe on new Medical Devices Regulations, MRA with Switzerland and Health Union package. Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Daphne von Buxhoeveden (Cabinet member)
- Giorgios Rossides (Cabinet member)
-
Date 10 Dec 2020 Location Brussels Subject VC Meeting - The role of medical technologies in the fight against antimicrobial resistance and healthcare acquired infections Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Annukka Ojala (Cabinet member)
- Daphne von Buxhoeveden (Cabinet member)
-
Date 06 Nov 2020 Location Brussels - virtual Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 30 Sep 2020 Location Online Subject Call with pharmaceutical and medical device supply Chain on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
- Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Sep 2020 Location Brussels Subject Green Paper on Ageing; cardiovascular diseases; innovative technologies Cabinet Cabinet of Vice-President Dubravka Šuica Portfolio Democracy and Demography Attending - Astrid Dentler (Cabinet member)
-
Date 29 Jun 2020 Location Online Subject Call with pharmaceutical and medical device industry associations on COVID-19 Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
- Giorgios Rossides (Cabinet member)
- Karolina Herbout-Borczak (Cabinet member)
Other Lobbyists -
Date 29 Jun 2020 Location Brussels Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 15 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 08 May 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 29 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 23 Apr 2020 Location Videconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 17 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 09 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 06 Apr 2020 Location Brussels, phone call Subject COVID 19 in vitro diagnostic access and availability for Europe DG Health and Food Safety Attending - Anne Bucher (Director-General)
-
Date 03 Apr 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 03 Apr 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 27 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 20 Mar 2020 Location Videoconference Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Thierry Breton (Commissioner)
Other Lobbyists -
Date 13 Mar 2020 Location Brussels Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak Cabinet Cabinet of Commissioner Stella Kyriakides Portfolio Health Attending - Stella Kyriakides (Commissioner)
Other Lobbyists -
Date 05 Sep 2019 Location Brussels Subject Medical Devices (Mr Bermig attended the meeting organized by Commissioner Oettinger) Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
Other Lobbyists -
Date 15 Jun 2018 Location Brussels, Berl Subject HTA Cabinet Cabinet of Commissioner Vytenis Andriukaitis Portfolio Health & Food Safety Attending - Vytenis Andriukaitis (Commissioner)
- Annika Nowak (Cabinet member)
Other Lobbyists -
Date 15 Jun 2018 Location Brussels Subject Future closer collaboration and FP9 Cabinet Cabinet of Commissioner Carlos Moedas Portfolio Research, Science and Innovation Attending - Manuel Nobre Goncalves (Cabinet member)
-
Date 08 Nov 2017 Location Brussels Subject Strategic public procurement oraz HTA co-operation Cabinet Cabinet of Commissioner Elżbieta Bieńkowska Portfolio Internal Market, Industry, Entrepreneurship and SMEs Attending - Rolf Carsten Bermig (Cabinet member)
- Agnieszka Drzewoska (Cabinet member)